Asahi Kasei Pharma America Corporation
2 clinical trials · Sponsor
◉ Watch Asahi Kasei Pharma America Corporation
| Record | Firm | Date |
|---|---|---|
| The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy (NCT03517501) | Asahi Kasei Pharma America Corporation | 2019-07-01 |
| Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy (NCT01598831) | Asahi Kasei Pharma America Corporation | 2012-10-29 |
Track Asahi Kasei Pharma America Corporation automatically
Every clearance here is in the API, with alerts when new ones post.